Global and United States Type 2 Diabetes Therapeutics Market Report & Forecast 2024-2031

Report ID: 1827569 | Published Date: Sep 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Type 2 Diabetes Therapeutics Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Type 2 Diabetes Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Type 2 Diabetes Therapeutics Market Size for the Year 2017-2028
        1.2.2 Global Type 2 Diabetes Therapeutics Market Size for the Year 2017-2028
    1.3 Type 2 Diabetes Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Type 2 Diabetes Therapeutics in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Type 2 Diabetes Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Type 2 Diabetes Therapeutics Market Dynamics
        1.4.1 Type 2 Diabetes Therapeutics Industry Trends
        1.4.2 Type 2 Diabetes Therapeutics Market Drivers
        1.4.3 Type 2 Diabetes Therapeutics Market Challenges
        1.4.4 Type 2 Diabetes Therapeutics Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Type 2 Diabetes Therapeutics by Type
    2.1 Type 2 Diabetes Therapeutics Market Segment by Type
        2.1.1 DPP-4 Inhibitors
        2.1.2 Biguanides
        2.1.3 Insulins
        2.1.4 SGLT-2 Inhibitors
        2.1.5 α-Glucosidase Inhibitors
        2.1.6 Other
    2.2 Global Type 2 Diabetes Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.3 Global Type 2 Diabetes Therapeutics Market Size by Type (2017-2028)
    2.4 United States Type 2 Diabetes Therapeutics Market Size by Type (2017, 2022 & 2028)
    2.5 United States Type 2 Diabetes Therapeutics Market Size by Type (2017-2028)
3 Type 2 Diabetes Therapeutics by Application
    3.1 Type 2 Diabetes Therapeutics Market Segment by Application
        3.1.1 Children
        3.1.2 Middle-Aged Person
        3.1.3 Aged
    3.2 Global Type 2 Diabetes Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.3 Global Type 2 Diabetes Therapeutics Market Size by Application (2017-2028)
    3.4 United States Type 2 Diabetes Therapeutics Market Size by Application (2017, 2022 & 2028)
    3.5 United States Type 2 Diabetes Therapeutics Market Size by Application (2017-2028)
4 Global Type 2 Diabetes Therapeutics Competitor Landscape by Company
    4.1 Global Type 2 Diabetes Therapeutics Market Size by Company
        4.1.1 Top Global Type 2 Diabetes Therapeutics Companies Ranked by Revenue (2021)
        4.1.2 Global Type 2 Diabetes Therapeutics Revenue by Player (2017-2022)
    4.2 Global Type 2 Diabetes Therapeutics Concentration Ratio (CR)
        4.2.1 Type 2 Diabetes Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Type 2 Diabetes Therapeutics in 2021
        4.2.3 Global Type 2 Diabetes Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Type 2 Diabetes Therapeutics Headquarters, Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Type 2 Diabetes Therapeutics Headquarters and Area Served
        4.3.2 Global Type 2 Diabetes Therapeutics Companies Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Type 2 Diabetes Therapeutics Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Type 2 Diabetes Therapeutics Market Size by Company
        4.5.1 Top Type 2 Diabetes Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Type 2 Diabetes Therapeutics Revenue by Players (2020, 2021 & 2022)
5 Global Type 2 Diabetes Therapeutics Market Size by Region
    5.1 Global Type 2 Diabetes Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Type 2 Diabetes Therapeutics Market Size by Region (2017-2028)
        5.2.1 Global Type 2 Diabetes Therapeutics Market Size by Region: 2017-2022
        5.2.2 Global Type 2 Diabetes Therapeutics Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Type 2 Diabetes Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Type 2 Diabetes Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Type 2 Diabetes Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Type 2 Diabetes Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Type 2 Diabetes Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Type 2 Diabetes Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Type 2 Diabetes Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Type 2 Diabetes Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Type 2 Diabetes Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Type 2 Diabetes Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 AstraZeneca
        7.1.1 AstraZeneca Company Details
        7.1.2 AstraZeneca Business Overview
        7.1.3 AstraZeneca Type 2 Diabetes Therapeutics Introduction
        7.1.4 AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.1.5 AstraZeneca Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Type 2 Diabetes Therapeutics Introduction
        7.2.4 Novartis Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Novo Nordisk
        7.3.1 Novo Nordisk Company Details
        7.3.2 Novo Nordisk Business Overview
        7.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Introduction
        7.3.4 Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.3.5 Novo Nordisk Recent Development
    7.4 Boehringer Ingelheim
        7.4.1 Boehringer Ingelheim Company Details
        7.4.2 Boehringer Ingelheim Business Overview
        7.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Introduction
        7.4.4 Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.4.5 Boehringer Ingelheim Recent Development
    7.5 Bristol-Myers Squibb
        7.5.1 Bristol-Myers Squibb Company Details
        7.5.2 Bristol-Myers Squibb Business Overview
        7.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Introduction
        7.5.4 Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.5.5 Bristol-Myers Squibb Recent Development
    7.6 Eli Lilly
        7.6.1 Eli Lilly Company Details
        7.6.2 Eli Lilly Business Overview
        7.6.3 Eli Lilly Type 2 Diabetes Therapeutics Introduction
        7.6.4 Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.6.5 Eli Lilly Recent Development
    7.7 Merck
        7.7.1 Merck Company Details
        7.7.2 Merck Business Overview
        7.7.3 Merck Type 2 Diabetes Therapeutics Introduction
        7.7.4 Merck Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.7.5 Merck Recent Development
    7.8 Sanofi
        7.8.1 Sanofi Company Details
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Type 2 Diabetes Therapeutics Introduction
        7.8.4 Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2017-2022)
        7.8.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Type 2 Diabetes Therapeutics Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Type 2 Diabetes Therapeutics Market Trends
    Table 3. Type 2 Diabetes Therapeutics Market Drivers
    Table 4. Type 2 Diabetes Therapeutics Market Challenges
    Table 5. Type 2 Diabetes Therapeutics Market Restraints
    Table 6. Global Type 2 Diabetes Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Type 2 Diabetes Therapeutics Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Type 2 Diabetes Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Type 2 Diabetes Therapeutics Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Type 2 Diabetes Therapeutics Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Type 2 Diabetes Therapeutics Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Type 2 Diabetes Therapeutics Revenue Share by Player, 2017-2022
    Table 13. Global Type 2 Diabetes Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Type 2 Diabetes Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Therapeutics as of 2021)
    Table 15. Top Players of Type 2 Diabetes Therapeutics in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Type 2 Diabetes Therapeutics Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Type 2 Diabetes Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Type 2 Diabetes Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Type 2 Diabetes Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Type 2 Diabetes Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Type 2 Diabetes Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Type 2 Diabetes Therapeutics Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Type 2 Diabetes Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Type 2 Diabetes Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Type 2 Diabetes Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Type 2 Diabetes Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Type 2 Diabetes Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. AstraZeneca Company Details
    Table 31. AstraZeneca Business Overview
    Table 32. AstraZeneca Type 2 Diabetes Therapeutics Product
    Table 33. AstraZeneca Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 34. AstraZeneca Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Type 2 Diabetes Therapeutics Product
    Table 38. Novartis Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Novo Nordisk Company Details
    Table 41. Novo Nordisk Business Overview
    Table 42. Novo Nordisk Type 2 Diabetes Therapeutics Product
    Table 43. Novo Nordisk Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 44. Novo Nordisk Recent Development
    Table 45. Boehringer Ingelheim Company Details
    Table 46. Boehringer Ingelheim Business Overview
    Table 47. Boehringer Ingelheim Type 2 Diabetes Therapeutics Product
    Table 48. Boehringer Ingelheim Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 49. Boehringer Ingelheim Recent Development
    Table 50. Bristol-Myers Squibb Company Details
    Table 51. Bristol-Myers Squibb Business Overview
    Table 52. Bristol-Myers Squibb Type 2 Diabetes Therapeutics Product
    Table 53. Bristol-Myers Squibb Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 54. Bristol-Myers Squibb Recent Development
    Table 55. Eli Lilly Company Details
    Table 56. Eli Lilly Business Overview
    Table 57. Eli Lilly Type 2 Diabetes Therapeutics Product
    Table 58. Eli Lilly Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 59. Eli Lilly Recent Development
    Table 60. Merck Company Details
    Table 61. Merck Business Overview
    Table 62. Merck Type 2 Diabetes Therapeutics Product
    Table 63. Merck Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 64. Merck Recent Development
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Type 2 Diabetes Therapeutics Product
    Table 68. Sanofi Revenue in Type 2 Diabetes Therapeutics Business (2017-2022) & (US$ Million)
    Table 69. Sanofi Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Type 2 Diabetes Therapeutics Product Picture
    Figure 2. Global Type 2 Diabetes Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Type 2 Diabetes Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. United States Type 2 Diabetes Therapeutics Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Type 2 Diabetes Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 6. United States Type 2 Diabetes Therapeutics Market Share in Global 2017-2028
    Figure 7. Type 2 Diabetes Therapeutics Report Years Considered
    Figure 8. Product Picture of DPP-4 Inhibitors
    Figure 9. Product Picture of Biguanides
    Figure 10. Product Picture of Insulins
    Figure 11. Product Picture of SGLT-2 Inhibitors
    Figure 12. Product Picture of α-Glucosidase Inhibitors
    Figure 13. Product Picture of Other
    Figure 14. Global Type 2 Diabetes Therapeutics Market Share by Type in 2022 & 2028
    Figure 15. Global Type 2 Diabetes Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. Global Type 2 Diabetes Therapeutics Market Share by Type (2017-2028)
    Figure 17. United States Type 2 Diabetes Therapeutics Market Share by Type in 2022 & 2028
    Figure 18. United States Type 2 Diabetes Therapeutics Market Size by Type (2017-2028) & (US$ Million)
    Figure 19. United States Type 2 Diabetes Therapeutics Market Share by Type (2017-2028)
    Figure 20. Product Picture of Children
    Figure 21. Product Picture of Middle-Aged Person
    Figure 22. Product Picture of Aged
    Figure 23. Global Type 2 Diabetes Therapeutics Market Share by Application in 2022 & 2028
    Figure 24. Global Type 2 Diabetes Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Type 2 Diabetes Therapeutics Market Share by Application (2017-2028)
    Figure 26. United States Type 2 Diabetes Therapeutics Market Share by Application in 2022 & 2028
    Figure 27. United States Type 2 Diabetes Therapeutics Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Type 2 Diabetes Therapeutics Market Share by Application (2017-2028)
    Figure 29. North America Type 2 Diabetes Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Type 2 Diabetes Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Type 2 Diabetes Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Type 2 Diabetes Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Type 2 Diabetes Therapeutics Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Type 2 Diabetes Therapeutics Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. AstraZeneca Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 58. Novartis Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 59. Novo Nordisk Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 60. Boehringer Ingelheim Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 62. Eli Lilly Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 63. Merck Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 64. Sanofi Revenue Growth Rate in Type 2 Diabetes Therapeutics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
Frequently Asked Questions
Type 2 Diabetes Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Type 2 Diabetes Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Type 2 Diabetes Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Asthma Therapeutics

Asthma Therapeutics market is segmented by region (country), players, by Type and by Application. ... Read More